Cargando…

Efficacy and tolerability of bilateral sustained-release dexamethasone intravitreal implants for the treatment of noninfectious posterior uveitis and macular edema secondary to retinal vein occlusion

PURPOSE: To report our experience with bilateral placement of dexamethasone 0.7 mg (DEX) sustained-release intravitreal implant in the management of noninfectious posterior uveitis or macular edema secondary to retinal vein occlusion. METHODS: A retrospective chart review of patients with bilateral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryder, Steven J, Iannetta, Danilo, Bhaleeya, Swetangi D, Kiss, Szilárd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484654/ https://www.ncbi.nlm.nih.gov/pubmed/26150689 http://dx.doi.org/10.2147/OPTH.S84207

Ejemplares similares

Intravitreal Dexamethasone Implants for Refractory Macular Edema in Eyes with Noninfectious Uveitis
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011)

Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
por: Matonti, Frederic, et al.
Publicado: (2012)

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail, Adnan, et al.
Publicado: (2018)

Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
por: Choi, Eun Young, et al.
Publicado: (2019)

Intravitreal therapeutic agents in noninfectious uveitic macular edema
por: Shah, Kunal Kaushik, et al.
Publicado: (2018)

The Effects of Intravitreal Bevacizumab in Infectious and Noninfectious Uveitic Macular Edema
por: Al-Dhibi, Hassan, et al.
Publicado: (2014)

Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
por: Lautredou, Cassandra C., et al.
Publicado: (2018)

Dexamethasone intravitreal implant for macular edema and some other rare indications in uveitis
por: Koksaldi, Seher, et al.
Publicado: (2023)

Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis
por: Saade, Joanna S., et al.
Publicado: (2021)

Evaluation of the Effectiveness of Treatment with Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Retinal Vein Occlusion
por: Donati, Simone, et al.
Publicado: (2018)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema and Uveitis: A Comprehensive Narrative Review
por: Kishore, Kamal, et al.
Publicado: (2022)

Bilateral Intravitreal Dexamethasone Implant for Retinitis Pigmentosa-Related Macular Edema
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine, Ilkka, et al.
Publicado: (2017)

Dexamethasone Intravitreal Implant Rescue Treatment for Bevacizumab Refractory Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Lee, Kyou Ho, et al.
Publicado: (2017)

Management of noninfectious posterior uveitis with intravitreal drug therapy
por: Tan, Hui Yi, et al.
Publicado: (2016)

Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis
por: Hanif, Junaid, et al.
Publicado: (2021)

Outcomes of Combination Therapy using Aflibercept and Dexamethasone Intravitreal Implant versus Dexamethasone Monotherapy for Macular Edema Secondary to Retinal Vein Occlusion
por: Harb, Walid, et al.
Publicado: (2021)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
por: Udaondo, Patricia, et al.
Publicado: (2011)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
por: Yalamanchi, Shalini, et al.
Publicado: (2011)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose, Remya, et al.
Publicado: (2016)

The Efficacy and Safety of Dexamethasone Intravitreal Implant for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis of Randomized Controlled Trials
por: Xiaodong, Li, et al.
Publicado: (2022)

Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant
por: Niro, Alfredo, et al.
Publicado: (2018)

A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Bayat, Alper Halil, et al.
Publicado: (2019)

Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
por: Liang, Xuemei, et al.
Publicado: (2022)

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan, Annie, et al.
Publicado: (2011)

Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis
por: Sanders, Francis W B, et al.
Publicado: (2023)

Use of Intravitreal Triamcinolone in the Treatment of Macular Edema Related to Retinal Vein Occlusion
por: Sharma, Ashish, et al.
Publicado: (2008)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
por: Gutiérrez, Juan Carlos Mesa, et al.
Publicado: (2008)

Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion: A meta-analysis
por: Ji, Kaibao, et al.
Publicado: (2019)

Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa
por: Pielen, Amelie, et al.
Publicado: (2017)

Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
por: Huang, Yu-Te, et al.
Publicado: (2021)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario
por: Simsek, Mert, et al.
Publicado: (2018)

Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up
por: Nicula, Cristina, et al.
Publicado: (2020)

EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION
por: Sun, Zuhua, et al.
Publicado: (2017)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska, Biljana, et al.
Publicado: (2017)

Efficacy of intravitreal dexamethasone implant used as monotherapy for the treatment of macular edema in non-infectious uveitis: a retrospective analysis
por: Gupta, Rishi B., et al.
Publicado: (2023)

Microvascular changes in the recurrent cystoid macular edema secondary to posterior noninfectious uveitis on optical coherence tomography angiography
por: Albano, Valeria, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jbjkokcssipfov25uvvnqcaakj